Clincosm LogoSign in Get a demo

Hypophosphatemia as a Predictor in Surgical Resuscitation Sepsis

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT03740802
Collaborator
(none)
264
Enrollment
1
Location
2.4
Actual Duration (Months)
110.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Retrospective study in the surgical intensive care unit of the Brest Teaching Hospital (France) during a 6-months period (January 2015 -May 2015) to study the independent association between hypophosphatemia and 28-day infection.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    264 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Evaluation of Hypophosphatemia as a Predictor of Sepsis in Surgical Resuscitation Units.
    Actual Study Start Date :
    Jan 26, 2018
    Actual Primary Completion Date :
    Apr 9, 2018
    Actual Study Completion Date :
    Apr 9, 2018

    Outcome Measures

    Primary Outcome Measures

    1. Number of patients with sepsis within 28 days after ICU admission [28 days since the ICU admission]

      Sepsis was defined according to the criteria of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adults
    Exclusion Criteria:

    • Less than 18 years old

    • Infected at admission

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHRU de Brest Brest France 29609

    Sponsors and Collaborators

    • University Hospital, Brest

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Brest
    ClinicalTrials.gov Identifier:
    NCT03740802
    Other Study ID Numbers:
    • PORPOISE2-REA (29BRC18.0022)
    First Posted:
    Nov 14, 2018
    Last Update Posted:
    Nov 27, 2018
    Last Verified:
    Jan 1, 2018
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Hypophosphatemia

    Study Results

    No Results Posted as of Nov 27, 2018